Key facts
- Axon’s last known valuation is $15.6M (Feb 2025).
- It has raised $4.1M; the latest was Seed Round ($4.1M) in Feb 2025.
- Notable investors include Andreessen Horowitz, Northzone Ventures, Oxford Science Enterprises, EWOR, Concept Ventures (London) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Axon
- ·The full record, as it builds
Funding rounds
No funding rounds for Axon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axon
Developer of brain-inspired artificial intelligence systems with low-latency infrastructure and intelligent models intended to optimize performance in financial markets. The company offers integrated research and trading capabilities focused on speed and adaptive intelligence by using neuroscience-inspired architecture and proprietary algorithms, enabling institutional clients to execute high-frequency strategies with enhanced precision and responsiveness.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 4
- Website
- axonlabs.co/
- Ownership
- Privately Held (backing)
Axon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axon in its N-PORT filings yet. We sweep new filings monthly.